Cano Health (NYSE:CANO – Get Rating) had its price objective hoisted by Piper Sandler to $1.00 in a research report report published on Tuesday morning, The Fly reports.
Separately, Citigroup reduced their price target on Cano Health from $5.00 to $4.00 in a research report on Friday, May 12th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Cano Health currently has an average rating of Hold and an average target price of $3.64.
Cano Health Trading Up 0.8 %
Cano Health stock opened at $1.28 on Tuesday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 2.06. The business’s fifty day simple moving average is $1.21 and its two-hundred day simple moving average is $1.50. Cano Health has a 12 month low of $0.76 and a 12 month high of $9.75. The company has a market capitalization of $676.07 million, a price-to-earnings ratio of -1.29 and a beta of -0.02.
In other news, CFO Brian D. Koppy sold 23,591 shares of the stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $1.27, for a total value of $29,960.57. Following the transaction, the chief financial officer now directly owns 802,570 shares of the company’s stock, valued at $1,019,263.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 54.40% of the company’s stock.
Institutional Trading of Cano Health
Hedge funds have recently modified their holdings of the stock. State Street Corp lifted its position in shares of Cano Health by 3.4% in the first quarter. State Street Corp now owns 4,542,095 shares of the company’s stock valued at $4,133,000 after acquiring an additional 149,752 shares in the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Cano Health in the first quarter valued at approximately $648,000. Geode Capital Management LLC increased its holdings in shares of Cano Health by 4.7% in the first quarter. Geode Capital Management LLC now owns 3,179,945 shares of the company’s stock valued at $2,894,000 after purchasing an additional 142,953 shares during the last quarter. Glenview Capital Management LLC acquired a new stake in shares of Cano Health in the first quarter valued at approximately $865,000. Finally, Bayesian Capital Management LP acquired a new stake in shares of Cano Health in the first quarter valued at approximately $122,000. Hedge funds and other institutional investors own 25.56% of the company’s stock.
Cano Health Company Profile
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
- Get a free copy of the StockNews.com research report on Cano Health (CANO)
- How to Calculate Stock Growth
- 7 Best Retail Stocks to Invest in
- 3 Home Improvement Stocks to Renovate Your Portfolio
- Beam Global Shines Brightly in the EV Infrastructure Space
- Canoo Bottoms As Production Ramp Gets Closer
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.